BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33046735)

  • 21. Analysis of SDHD promoter mutations in various types of melanoma.
    Scholz SL; Horn S; Murali R; Möller I; Sucker A; Sondermann W; Stiller M; Schilling B; Livingstone E; Zimmer L; Reis H; Metz CH; Zeschnigk M; Paschen A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
    Oncotarget; 2015 Sep; 6(28):25868-82. PubMed ID: 26327518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. F-18 fluorodeoxyglucose positron emission tomography/computed tomography in conjunctival melanoma with recurrence.
    Jain A; John AR; Kishore B; Vishnoi MG; Pandit AG; Sharma A; Jaimini A; Jain M; Singh A
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S240-S242. PubMed ID: 33380688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.
    Ciavarella S; Vegliante MC; Fabbri M; De Summa S; Melle F; Motta G; De Iuliis V; Opinto G; Enjuanes A; Rega S; Gulino A; Agostinelli C; Scattone A; Tommasi S; Mangia A; Mele F; Simone G; Zito AF; Ingravallo G; Vitolo U; Chiappella A; Tarella C; Gianni AM; Rambaldi A; Zinzani PL; Casadei B; Derenzini E; Loseto G; Pileri A; Tabanelli V; Fiori S; Rivas-Delgado A; López-Guillermo A; Venesio T; Sapino A; Campo E; Tripodo C; Guarini A; Pileri SA
    Ann Oncol; 2018 Dec; 29(12):2363-2370. PubMed ID: 30307529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions.
    Seregard S; Oskarsson M; Spângberg B
    Exp Eye Res; 1999 Dec; 69(6):671-6. PubMed ID: 10620396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor Microenvironment Characterization in Glioblastoma Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.
    Zhang J; Xiao X; Zhang X; Hua W
    J Mol Neurosci; 2020 May; 70(5):738-750. PubMed ID: 32006162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk stratification of cutaneous melanoma reveals carcinogen metabolism enrichment and immune inhibition in high-risk patients.
    Li X; Cai Y
    Aging (Albany NY); 2020 Aug; 12(16):16457-16475. PubMed ID: 32858528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Murine Model for Metastatic Conjunctival Melanoma.
    de Waard NE; Cao J; McGuire SP; Kolovou PE; Jordanova ES; Ksander BR; Jager MJ
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2325-33. PubMed ID: 25722211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Data Mining of Prognostic Microenvironment-Related Genes in Clear Cell Renal Cell Carcinoma: A Study with TCGA Database.
    Chen B; Chen W; Jin J; Wang X; Cao Y; He Y
    Dis Markers; 2019; 2019():8901649. PubMed ID: 31781309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With BRAF Mutations.
    Larsen AC; Dahmcke CM; Dahl C; Siersma VD; Toft PB; Coupland SE; Prause JU; Guldberg P; Heegaard S
    JAMA Ophthalmol; 2015 Nov; 133(11):1295-303. PubMed ID: 26425792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 32. Integrated Analysis of the ETS Family in Melanoma Reveals a Regulatory Role of ETV7 in the Immune Microenvironment.
    Qu H; Zhao H; Zhang X; Liu Y; Li F; Sun L; Song Z
    Front Immunol; 2020; 11():612784. PubMed ID: 33424867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PD-L1 Expression in 65 Conjunctival Melanomas and Its Association with Clinical Outcome.
    Lassalle S; Nahon-Esteve S; Frouin E; Boulagnon-Rombi C; Josselin N; Cassoux N; Barnhill R; Scheller B; Baillif S; Hofman P
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Validation of a CD8+ T Cell Infiltration-Related Signature for Melanoma Patients.
    Yuan Y; Zhu Z; Lan Y; Duan S; Zhu Z; Zhang X; Li G; Qu H; Feng Y; Cai H; Song Z
    Front Immunol; 2021; 12():659444. PubMed ID: 34040608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new cell line from a recurrent conjunctival melanoma.
    Keijser S; Maat W; Missotten GS; de Keizer RJ
    Br J Ophthalmol; 2007 Nov; 91(11):1566-7. PubMed ID: 17947278
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
    Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
    Shields CL; Shields JA; Gündüz K; Cater J; Mercado GV; Gross N; Lally B
    Arch Ophthalmol; 2000 Nov; 118(11):1497-507. PubMed ID: 11074806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
    Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
    Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas.
    Griewank KG; Westekemper H; Murali R; Mach M; Schilling B; Wiesner T; Schimming T; Livingstone E; Sucker A; Grabellus F; Metz C; Süsskind D; Hillen U; Speicher MR; Woodman SE; Steuhl KP; Schadendorf D
    Clin Cancer Res; 2013 Jun; 19(12):3143-52. PubMed ID: 23633454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
    Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J
    Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.